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Astroglial changes in the zona 
incerta in response to motor cortex 
stimulation in a rat model of 
chronic neuropathy
Myeounghoon cha  1, Kyung Hee Lee  2 & Bae Hwan Lee  1,3*
Although astrocytes are known to regulate synaptic transmission and affect new memory formation by 
influencing long-term potentiation and functional synaptic plasticity, their role in pain modulation is 
poorly understood. Motor cortex stimulation (MCS) has been used to reduce neuropathic pain through 
the incertothalamic pathway, including the primary motor cortex (M1) and the zona incerta (ZI). 
However, there has been no in-depth study of these modulatory effects and region-specific changes 
in neural plasticity. In this study, we investigated the effects of MCS-induced pain modulation as well 
as the relationship between the ZI neuroplasticity and MCS-induced pain alleviation in neuropathic 
pain (NP). MCS-induced threshold changes were evaluated after daily MCS. Then, the morphological 
changes of glial cells were compared by tissue staining. In order to quantify the neuroplasticity, MAP2, 
PSD95, and synapsin in the ZI and M1 were measured and analyzed with western blot. In behavioral 
test, repetitive MCS reduced NP in nerve-injured rats. We also observed recovered GFAP expression in 
the NP with MCS rats. In the NP with sham MCS rats, increased CD68 level was observed. In the NP with 
MCS group, increased mGluR1 expression was observed. Analysis of synaptogenesis-related molecules 
in the M1 and ZI revealed that synaptic changes occured in the M1, and increased astrocytes in the 
ZI were more closely associated with pain alleviation after MCS. Our findings suggest that MCS may 
modulate the astrocyte activities in the ZI and synaptic changes in the M1. Our results may provide new 
insight into the important and numerous roles of astrocytes in the formation and function.
Chronic neuropathic pain (NP) is the result of primary lesion in peripheral nerve and/or central nervous system 
(CNS) dysfunction in the absence of nociceptor stimulation1. This multidimensional clinical entity is mediated by 
various pathophysiological mechanisms, making its treatment difficult2,3. Neuropathic pain refractory to medi-
cation has been treated with invasive methods, such as selective lesioning and electrical stimulation of the central 
or peripheral nervous system4.
MCS was initially applied to central pain secondary to thalamic stroke5,6. Over time, its usage expanded to 
various types of chronic pain. Repetitive MCS relieves approximately 45 to 75% of pain7,8, making it a viable 
option for patients with severe drug-refractory symptoms. Motor cortex stimulation (MCS) treatment was first 
used in the early 1990s to treat a patient with chronic, drug-resistant NP9. Despite the clinical use of MCS for 
pain reduction, the mechanisms underlying its effects remain unclear. The incertothalamic pathway was recently 
described as a novel system for regulating nociceptive processing in the thalamus10,11. In this pathway, the zona 
incerta (ZI) inhibits the flow of nociceptive and somatosensory information in the posterior thalamus (Po), and 
this is mediated by the cholinergic system10,12.
Modulation of the ZI activity by repeated MCS was shown to be effective in ameliorating chronic NP10. 
Increased spontaneous and evoked activity in the ZI is causally related to repetitive MCS10. These findings strongly 
implicate the ZI as a site of maladaptive plasticity in chronic pain modulation. Understanding MCS-induced 
plasticity is of fundamental neurobiological importance, and is probably a requirement for developing effective 
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strategies to promote recovery following brain damage13. However, little is known about MCS-induced neuronal 
changes in pain modulation.
The aim of this study was to explore how MCS regulates synaptic plasticity in the ZI. In particular, we focused 
on the relationship between pain modulation after MCS and neuronal plastic changes in the ZI, which has been 
associated with astrocyte-induced synapse modulation. Using a rat model of chronic NP, we compared neuronal 
changes after MCS and measured various markers of astrocyte plasticity in the ZI. Our findings suggest that MCS 
may modulate astrocyte activities in the ZI and synaptic changes in the M1. Furthermore, these results clarify the 
mechanism of MCS-induced analgesic effects in the setting of chronic NP.
Results
Development of NP and effects of MCS. We previously reported that rats with peripheral nerve injury 
develop mechanical allodynia of the hind paw14. Consistent with this, we measured a significant reduction in the 
mechanical withdrawal threshold of the hind paw within 14 days of nerve injury. As shown in Fig. 1B, ipsilateral 
hind paw mechanical thresholds gradually decreased: 32.48 ± 1.66 g (pre), 28.89 ± 1.46 g (Day 1), 11.96 ± 0.97 g 
(Day 4), 9.64 ± 1.11 g (Day 7) and 4.61 ± 0.47 g (day 14). There was no significant decrease in sham animals (from 
35.36 ± 1.36 g to 32.65 ± 0.47 g, p < 0.01 vs. NP rats). Importantly, repetitive MCS treatment reduced nerve inju-
ry-induced pain in rats. The withdrawal threshold of NP rats gradually increased following repetitive stimulation 
of the M1 cortex (p < 0.05 vs. NP + Sham stim).
Astrocytes in ZI. We observed astrocytes and neurons in the ZI area from −3.3 to −4.0 mm of the bregma. 
Figure 2A depicts the ZI area, and Fig. 2B–D show representative examples of astrocytes in different groups. A 
previous study reported pain-related neural activity in the dorsal and ventrolateral ZI10. We observed lower the 
ZI glial fibrillary acidic protein (GFAP) expression in NP + Sham stim. rats than in the control rats. Following 
repetitive MCS, GFAP expression in the ZI was increased compared to NP + Sham stim. group. We also per-
formed western blotting to quantify GFAP expression levels in each group. Figure 2E shows a comparison of 
neuron-specific protein expressions. GFAP in the ZI significantly decreased after nerve injury (control, 100 ± 5.1; 
NP + Sham stim., 73.63 ± 9.69; NP + MCS, 105.93 ± 5.67; Fig. 2F). We quantified NeuN expression in the ZI 
region. However, the regional and cellular distributions of NeuN did not differ between the control and NP rats 
(control, 100 ± 4.5; NP + Sham stim., 105.03 ± 11.62; NP + MCS, 104.91 ± 7.2; Fig. 2G).
Effect of MCS on synaptic plasticity. Astrocytes and microglia are actively involved in synaptic plasticity. 
Microglia are a type of neuroglia (glial cells) that are resident macrophage cells in the CNS. In our results, the 
astrocyte-microglia coexpression in the ZI seemed to increase after neuropathy-induced plasticity, as assessed 
with immunohistochemistry. CD68, a microglial marker in mammalian tissue, was used to identify microglia. In 
our results, CD68 expression levels were observed in the ZI of NP + Sham stim. rats. Coexpression of astrocytes 
and microglial cells was observed in the ZI area (Fig. 3). However, in the control and NP + MCS rats, we did 
not observe coexpression or plastic changes in astrocytes in the ZI area (Control, 100 ± 5.77; NP + Sham stim., 
402.773 ± 23.39; NP + MCS, 111.36 ± 10.3). These results support the interpretation that neuropathic pain is 
associated with abnormal GFAP declines in the ZI, which are coupled with elevated CD68 expression.
Glutamatergic neurotransmission is involved in most aspects of normal brain function, and the presence 
of metabotropic glutamate receptor 1 (mGluR1) indicates synaptic plasticity. In order to identify the expres-
sion of glutamatergic transmission, mGluR1 and GFAP were examined. In NP + MCS rats, the intense mGluR1 
expression near astrocytes in the ZI demonstrated that highly activated neurons interacted with glial cells in 
the ZI (Control, 100 ± 7.82; NP + Sham stim., 70.26 ± 8.14; NP + MCS, 111.67 ± 6.21; Fig. 4). Figure 4 shows a 
neuronal-glial synapse in the ZI of an NP + MCS rat.
Figure 1. Identification of MCS site and mechanical threshold changes. (A) MCS electrode position. Platinum 
silver electrodes were placed stereotaxically over the primary motor cortex (M1) area contralateral to the 
injured hind paw; the location was defined by its coordinates with respect to bregma (red dot). (B) Changes 
in mechanical allodynia after nerve injury. On each test day (1, 4, 7, and 14 days after surgery), nerve-injured 
rats showed a significantly decreased mechanical withdrawal threshold compared to sham-operated group (C). 
Mechanical threshold changes between groups were compared in daily post-MCS session.
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Specificity of MCS effects. Based on the abovementioned results, we hypothesized that increased mGluR 
expression in neuronal-glial synapses was related to repetitive MCS, and that increased tripartite complexes 
would lead to the generation of neurons and synapses. To test this hypothesis, we measured the protein expres-
sion levels of several major molecules related to synaptic plasticity, including MAP2, PSD95, and synapsin, in the 
M1 cortex and ZI area (Fig. 5A). The levels of these three proteins were upregulated in the M1 of NP + MCS rats 
(n = 3) compared to the M1 of NP + Sham stim. rats (n = 3). Protein expression levels were also measured in the 
ZI; however, MAP2, PSD95, and synapsin levels were not significantly increased in that area (Fig. 5B, p > 0.05).
Figure 2. Astrocyte expression in the ZI. (A) Location of the ZI in the subthalamus. Box indicates the location 
of the ZI. (B) Astrocytes (GFAP, green) in the ZI of a control rat. (C) Astrocytes in the ZI of an NP rat 24 days 
after nerve injury, showing decreased GFAP expression compared to the control. (D) After 10 days of MCS 
sessions, GFAP expression levels in the ZI were compared. Repetitive M1 stimulation contributed to the 
restoration of GFAP expression in the ZI. (Scale bars = 200 µm.) (E) GFAP expression was compared among 
groups. Activity was normalized to the protein concentration. (F,G) Expression levels of GFAP and NeuN 
are shown as % changes compared to the control rats. Error bars indicate the standard errors calculated from 
three independent experiments. After nerve injury, GFAP protein levels were significantly reduced in the 
ZI. Following repetitive MCS, GFAP protein expression increased (p < 0.05). However, NeuN levels did not 
significantly change after MCS. Punctured ZI tissues were subjected to western blotting with GFAP or NeuN 
antibodies. Full-length blots are presented in Supplementary Fig. S1.
Figure 3. CD68 expression in the ZI of the rats. In order to identify protein expression by microglia, brain 
slices were labeled with CD68 (red), GFAP (green) antibodies, and DAPI (blue). CD68-positive signals were 
compared in each group. NP + MCS rats had no effect on the morphological change in CD68-positive signal. 
Frequent co-occurrence of astrocytes and microglial cells was observed in NP + Sham stim. rats. (Scale 
bars = 20 µm).
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Discussion
We evaluated the changes in chronic NP-induced neural plasticity following MCS by assessing behavior, mor-
phology, and local synaptic protein expression. As in our previous studies, peripheral nerve injury induced sig-
nificant hind limb hyperalgesia, as evidenced by lowered withdrawal thresholds14. In addition, we observed an 
increased mechanical threshold after repetitive MCS, and found that NP decreased GFAP expression in the ZI. 
The reduction in astrocyte expression in the the ZI of NP + Sham stim. rats were consistent with maladaptive 
incertothalamic neuronal changes10. The restoration of GFAP expression following MCS suggests that protein 
expression by astrocytes is involved in pain modulation and synaptic plasticity. Furthermore, the increased 
expressions in glial cells and mGluR1 suggest alteration of synaptic plasticity in the ZI.
Changes in astrocyte distribution in the ZI. Astrocytes are the most abundant cell type found in the 
brain15. They have intricate morphological interactions with neurons, making them well-positioned to influence 
synaptic transmission. Fine astrocytic processes ensheathe neuronal synapses, forming a tripartite complex with 
pre- and post-synaptic neuronal components16. The traditionally recognized role of astrocytes was macrophagic 
activity or metabolic support17–19. However, more recent studies have led to reconsideration of their functions20,21. 
Astrocytes are now thought to play several active roles in the brain, including the secretion and absorption of 
neural transmitters and the maintenance of blood–brain barrier21–23.
Although current evidence from animal and human studies suggests pain-modulating effects of MCS, the 
reason for variation in astrocyte numbers following MCS remains to be elucidated13,24,25. Several hypotheses have 
been proposed to explain how MCS reduces pain14,26. Previous studies showed that MCS stimulates serotonin 
secretion in the periaqueductal gray, either directly or indirectly, via the ZI27,28. In addition, serotonin reactivity in 
the spinal cord indicates that MCS appears to be a descending modulator of NP28–30. We hypothesized that MCS 
Figure 4. Comparison of GFAP-mGluR1 expression in the ZI following MCS. Immunohistochemical analysis 
of mGluR1 and GFAP expression, showing the effects of MCS. Double labeling revealed mGluR1 expression 
(red) in neurons in the ZI. MCS induced changes in mGluR1-positive spines, which appeared near astrocytes in 
the ZI. Intense mGluR1 expression was observed in NP + MCS rats. (Scale bars = 20 µm).
Figure 5. Expression levels of synaptic molecules after MCS. (A) Comparison of synaptic molecule expression 
in the M1 (normalized to GAPDH). PSD95 and synapsin levels in the M1 were significantly increased 
(p < 0.05). Bar graph indicates the results of western blot analysis. In NP + Sham stim. rats, MAP2 level was 
100 ± 4.7, PSD95 level was 100 ± 35, and synapsin level was 100 ± 14. However, in NP + MCS group, PSD95 
(223.75 ± 26.85) and synapsin (219 ± 24.11) levels were significantly increased. MAP2 level was 136.08 ± 31.3. 
(B) Comparison of synaptic molecule expression in the ZI, showing no significant changes. In NP + Sham 
stim. rats and NP + MCS rats, MAP2 levels were 100 ± 8.5 and 126.46 ± 5.94, respectively; PSD95 levels were 
100 ± 16 and 92.23 ± 19.36, respectively; and synapsin levels were 100 ± 23 and 106.07 ± 32.88, respectively 
(all p < 0.05). Punctured M1 and ZI tissues were subjected to western blotting with antibodies against MAP2, 
PSD95, synapsin, and GAPDH antibodies. Full-length blots are presented in Supplementary Fig. S2.
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induces plasticity in the corticothalamic pathway, modulating synapses in the ZI. Our findings demonstrate a 
correlation between GFAP expression and the analgesic effect of MCS in a model of NP.
The effects of MCS treatments on behavioral parameters confirm that it decreases pain after nerve injury. After 
repetitive MCS sessions, astrocytic protein expression was restored. This suggests that the analgesic effects of MCS 
might persist due to joint neuronal and glial changes in the brain14,31, as the effect of MCS on pain may be related 
to astroglial changes in the ZI.
Microglia exhibited a strong increase in the expression of the microglia-specific marker CD68 in the ZI of 
NP + Sham stim. group. However, after the repetitive MCS period, protein levels of CD68 were reduced back to 
control levels. Similar results were observed in another study that applied tDCS to the primary motor cortex32. 
Although it is possible to deduce that protein expression by microglia is related to the synaptic changes in the ZI33, 
the relationship between the interaction of microglial activation and MCS-induced neuroplasticity is still remains 
controversial and is largely under investigation.
MCS induces a sudden change or interruption in the network status – either physiological or pathological34. 
Several studies showing increases or decreases in neuronal activity after MCS suggest that neuronal network 
reorganization occurs35–37. Therefore, it is also suspected that the MCS-induced modulation in the ZI is due to 
large-scale astrocytic activation representative of a new global status34. Cortical electric stimulation can directly 
activate astrocytes, which impacts neuronal signaling38,39. ATP released from astrocytes is degraded in the extra-
cellular space by ecto-ATPase to adenosine, which accumulates in the extracellular space around the electrode; 
adenosine is thought to be a key mediator promoting the efficacy of electric stimulation in suppressing abnormal 
neuronal activity39. Agnesi et al.40 reported that MCS produced analgesic effects concomitant with glutamate and 
adenosine release.
It remains unproven whether local synaptic modulation in astrocytic processes can extend to activate the 
whole astrocyte, whereby multiple synapses in different areas could be modulated, either uniformly or differen-
tially, allowing astrocytes to function as a network modulator.
Regulation of synaptic plasticity. Neuroplasticity is believed to be fundamental to MCS efficacy41. In 
this study, we showed significant changes in astrocytes in the ZI, which is responsible for NP modulation. In this 
study, to identify the MCS-induced neuronal change, we chose the ZI region and analyzed the expression levels 
of proteins. Concerning the regulation of nociceptive processing in the thalamus, the ZI (GABAergic nucleus 
located in the diencephalon) inhibits the flow of nociceptive and somatosensory information in the posterior 
thalamus. We hypothesized that the expression of astrocytes changed after NP and NP with MCS. For the com-
parison, we divided the animals into three groups (sham-operated control, NP + MCS, and NP + Sham stimula-
tion). Our western blot results show a change in the neuroglia in the ZI after neuropathic pain. In addition, when 
NP was followed by MCS, the reduced astrocytic protein expression recovered to the same value as the control 
(sham injury). The increase in GFAP expression after MCS and the structural changes in neuronal-glial synapses 
indicate that treatment induced significant plastic changes in the ZI. Regarding the relationship between synap-
togenesis and the increase in astrocyte number, this occurred only in the M1 cortex; there were no significant 
changes in synaptic protein expression in the ZI. These results suggest that epidural electrical stimulation induced 
the formation of new synapses in the M1 cortex, whereas the ZI produced astrocyte-induced pain control rather 
than synaptogenesis.
Structural neuronal changes occur in synapses in abnormal pain states, whereby astrocytes modulate sig-
nal processing and integration via complex neuronal–glial networks. This arrangement means that both 
astrocytes and neurons are likely to be affected by electrical stimulation42,43. These processes directly involve 
N-methyl-D-aspartate receptors (NMDARs) as well as specific gliotransmitters44. Astrocytes modulate NMDAR 
activity by releasing glutamate and providing the coagonist D-serine, which, similar to glycine, acts on distinct 
NMDAR populations44. Astrocyte-derived D-serine modulates NMDAR currents and is necessary for synaptic 
plasticity, as long-term potentiation does not occur in the absence of astrocytes but can be induced with exog-
enous D-serine45–47. Recent results suggest that D-serine release can be dynamic and provides the potential for 
astrocytes to induce rapid changes in NMDAR currents48–50.
involvement of astrocytes in synaptic plasticity after McS. We studied potential factors influenc-
ing structural plasticity in astrocytes after repetitive MCS. We previously reported MCS-induced pain modu-
lation in NP rats, as well as altered glial-neuronal interactions and morphological changes after nerve injury14. 
Coupled with our present results, the existing evidence supports a glial-neuronal interaction mechanism of pain 
pathogenesis.
Panatier et al.51,52 observed that astrocytic processes detect local synaptic activity (neurotransmitter release), 
which causes a local Ca2+-evoked response mediated through metabotropic glutamate subtype 5 receptor 
(mGluR5) activation. The literature suggests that such glial modulation may adjust synaptic efficacy so that it can 
conform to various plasticity events in specific brain regions, as adenosine release can either increase transmitter 
release (via presynaptic adenosine A2A receptor activation) or decrease it (via adenosine A1 receptor activation). 
Since astrocytes have very complex spatial relationships with adjacent neurons and maintain several types of 
synapses, it is possible to use different transmitters to interact with these structures53–55.
Several hypotheses have been proposed to explain how MCS ameliorates pain13,56–58. Here, we propose that 
MCS modulates synaptic strength by affecting astrocytes in the ZI, leading to synaptic plasticity. As astrocyte 
processes are ideally located in apposition with pre- and post-synaptic neuronal elements throughout the CNS, 
astrocytes likely regulate basal synaptic transmission and plasticity in the brain59,60. We observed decreased GFAP 
expression in the ZI after nerve injury, but expression was restored after MCS. In our results, intense mGluR1 
expressions were observed in NP + MCS rats. This could demonstrate that when presynaptic neuron releases 
glutamate, the neurotransmitter binds to receptors on the postsynaptic neuron, signaling the latter neuron to 
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be activated. This glutamate release is associated with a corresponding increase in calcium levels in the adjacent 
neurons. Modulating calcium levels could influence neural signaling patterns. The astrocytes wrap around syn-
apses, and they seem perfectly placed to play an active role in influencing the communication between neurons. 
Neuronal activity can directly affect calcium levels in neighboring astrocytes, after which the astrocytes can com-
plete the cycle by signaling back to the neurons through glutamate release19,20,43.
In the present study, we observed MCS-induced pain modulation in NP rats and morphological changes 
of astrocytes. These results support astrocyte expression changes as a mechanism of pain modulation. 
Understanding how astrocytic-neuronal relationships change after MCS in different cortical areas will clarify 
our understanding of pain modulation. Further knowledge of maladaptive synaptic changes would be helpful for 
designing treatments to control pain.
Methods
Animals and design overview. All animal experiments in this study were performed in accordance 
with the guidelines for the ethical use of conscious animals in pain research published by the International 
Association for the Study of Pain, and were approved by the Institutional Animal Care and Use Committee of 
Yonsei University Health System (protocol number 2016–0061). Male Sprague Dawley rats (N = 36, 9 weeks old, 
200–220 g; Koatech, Pyeongtaek, Korea) were housed in ventilated plastic cages (3 /cage) with soft bedding, and 
were maintained on a 12-/12-hour light/dark cycle (lights on at 07:00) at a constant temperature (22 ± 2 °C) and 
humidity (50 ± 10%) in an animal facility accredited by AAALAC International. The rats were divided into three 
groups. The animals were fed standard rat chow and had access to tap water ad libitum.
Animal model of np. The rats were anesthetized with intraperitoneal (i.p.) sodium pentobarbital (50 mg/
kg). The respiratory rate, corneal reflex, and tail-pinch response were monitored to ensure that the animals were 
sufficiently anesthetized. The surgical procedure and MCS setup were performed as we described previously14. 
Briefly, a segment of the sciatic nerve was exposed, and three divisions of the sciatic nerve (namely, the common 
peroneal, tibial, and sural nerves) were clearly separated. The tibial and sural nerves were ligated and transected, 
but the common peroneal nerve was left intact. Complete hemostasis was confirmed, and the wound was closed 
with muscle and skin sutures. Sham control group underwent the same operation without any nerve damage. All 
efforts were made to minimize animal suffering and reduce the number of animals used.
Stimulation electrode implantation. Two weeks after NP surgery, the animals were deeply anesthetized 
and placed on a thermoregulated heating pad in a stereotaxic frame. A local anesthetic (2% lidocaine) was applied 
to the incision sites 5 min before the surgery. A hole was made in the skull overlying the M1, and custom-made 
insulated bipolar platinum electrodes (height, 70 μm; exposed tip, 50 μm; distance between electrodes, 500 μm) 
were applied epidurally above the M1 at stereotaxic coordinates determined from previous MCS experiments 
(anterior, 1.8 mm; lateral, 2 mm), contralateral to the nerve injury site (Fig. 1A)61. The stimulation electrodes for 
MCS were held in place with two bone screws and dental cement.
Behavioral testing. Changes in the mechanical paw withdrawal threshold were measured at 1, 4, 7, and 14 
days after nerve or sham surgery. Rats were habituated for 10 min to the testing cages, which consisted of metal 
mesh floors under plastic domes. Mechanical allodynia was measured by assessing thresholds for hind paw with-
drawal upon stimulation with an electrically controlled von Frey filament (Ugo Basile, Varese, Italy). Licking or 
rapid withdrawal of the hind paw was considered a positive response. Mechanical forces were recorded for each 
withdrawal. The responses were measured seven times, and the means were calculated after the maximum and 
minimum values were excluded. Nociceptive tests were performed after MCS in awake rats for 10 days. Electrodes 
were connected to a stimulator (A385, WPI, Sarasota, FL, USA) for repetitive MCS. For MCS, the M1 of awake 
animals were stimulated for 30 min (continuously at 50 μA, 50 Hz, and 300 μs pulses). Sham MCS group under-
went the same procedure without any electrical stimulation. After the last behavioral test, the animals were anes-
thetized with urethane (1.25 mg/kg, i.p.), and tissue was collected for western blot and immunohistochemistry 
assays.
Western blot analysis. Rats were anesthetized and sacrificed prior to the ZI tissue collection (5 /group). 
The contralateral and ventrolateral ZI were quickly dissected, frozen on dry ice, and stored at −70 °C. For pro-
tein extraction, the samples of each group was pooled and homogenized with lysis buffer (ProPrep; Intron 
Biotechnology, Pyeongtaek, Korea) containing phosphatase inhibitors (Phosstop; Roche, Mannheim, Germany). 
The samples were centrifuged at 12,000 × g for 20 min at 4 °C, and then the supernatants were collected. Total 
protein concentrations were assessed with a spectrophotometer (Nano Drop ND-1000; Thermo Fisher Scientific, 
Waltham, MA, USA), and 30 mg of protein per well was denatured and run on 10% gels (Bio-Rad, Hercules, CA, 
USA). The proteins were transferred onto a polyvinylidene difluoride membrane (Merck Millipore, Darmstadt, 
Germany), and the membranes were blocked by incubation in 3% skim milk. The membranes were incu-
bated with primary antibodies against glial fibrillary acidic protein (GFAP) (1:5000; catalog ab7260, Abcam, 
Cambridge, UK), NeuN (1:5000; catalog MAB377, Millipore), microtubule-associated protein 2 (MAP2) (1:1000; 
catalog ab11267, Abcam), postsynaptic density-95 (PSD95) (1:500; catalog ab18258, Abcam), synapsin (1:500; 
catalog ab64581, Abcam), CD68 (1:1000; cat MAB1435, Millipore), and β-actin (1:10,000; catalog #3700; Cell 
Signaling Technology) or glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (1:10000; catalog #2118, Cell 
Signaling Technology, Danvers, MA, USA). The membranes were then incubated with the appropriate horse-
radish peroxidase-conjugated anti-rabbit or anti-mouse secondary antibodies (1:10,000; no. 7074 and 7076, Cell 
Signaling Technology). Protein bands were visualized by applying a chemiluminescent substrate (GE Healthcare, 
Little Chalfont, UK) and observed using LAS 4000 system (GE Healthcare). β-Actin and GAPDH were used as 
the loading controls. Immunoblotting experiments were replicated at least four times.
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immunohistochemistry. Anesthetized rats (4 /group) were perfused with 300 ml 0.9% NaCl and 4% par-
aformaldehyde in phosphate-buffered saline (PBS), and the extracted brains were stored with 4% paraformalde-
hyde and then 30% sucrose for 48 hours before being frozen in an embedding compound. The frozen whole brains 
were cut to a thickness of 30 μm with a cryostat (HM525, Thermo Scientific). The section slides were incubated 
overnight at 4 °C with primary antibodies against GFAP (1:1000; catalog ab7260, Abcam), NeuN (1:1000; catalog 
MAB377, Millipore), MAP2 (1:1000; catalog ab11267, Abcam), PSD95 (1:500; catalog ab18258, Abcam), syn-
apsin (1:500; catalog ab64581; Abcam), and CD68 (1:1000; cat MAB1435; Millipore), washed with PBS, and incu-
bated for 2 hours at room temperature with Alexa Fluor 488 and Cytm 3-conjugated AffiniPure F(ab’)2 Fragment 
Donkey Anti-Mouse IgG secondary antibodies (1:1000; Jackson ImmunoResearch, West Grove, PA, USA). DAPI 
was used for counterstaining. Immunofluorescent sections were imaged by LSM700 confocal microscope (Zeiss, 
Oberkochen, Germany) using 10× and 40× PlanApo oil-immersion lens. Briefly, 12 μm-thick confocal Z-stacks 
of the synaptic zone in ZI were captured. Three image stacks per rat (4 /group) were used for analyses. The num-
ber of cells with colocalized GFAP and mGluR1 was quantified. Three images per rat (4 /group) were used for 
analyses.
Statistical analysis. Behavioral test data were analyzed by two-way analysis of variance (ANOVA) fol-
lowed by Dunnett’s post-hoc multiple comparison test to determine significance. One-way ANOVA followed by 
Dunnet’s post-hoc analysis was used in immunohistochemistry and western blotting data. All statistical analyses 
were performed with SPSS 22.0 software (IBM Corporation, Armonk, NY, USA). All values are expressed as the 
mean ± standard error of the mean (SEM). P-values less than 0.05 were considered statistically significant.
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